World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
35263
World Ranking
9267
National Ranking
105

Hongyang Wang publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hongyang Wang sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 680 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hongyang Wang D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hongyang Wang sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hongyang Wang is affiliated with the Second Military Medical University in China. Their research spans multiple fields within biomedical science, with a primary focus on medicine and biochemistry, genetics, and molecular biology. The scientist's work includes extensive studies in molecular biology, cancer research, oncology, surgery, and immunology.

The main topics covered in Hongyang Wang's research include:

  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Genomics and Diagnostics
  • MicroRNA in disease regulation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver physiology and pathology
  • Cancer Immunotherapy and Biomarkers
  • Hearing, Cochlea, Tinnitus, Genetics

The scientist has published in a variety of frequently appearing venues such as:

  • Cancer Letters
  • PubMed
  • Research Square (Research Square)
  • Frontiers in Immunology
  • Acta Pharmacologica Sinica

Hongyang Wang has collaborated extensively with several co-authors, including:

  • Lei Chen (30 joint publications)
  • Xinyao Qiu (19 joint publications)
  • Liwei Dong (18 joint publications)
  • Bo Zheng (18 joint publications)
  • Siyun Shen (18 joint publications)

Their notable recent papers include:

  • COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas, 2021, published in Cell
  • Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing, 2020, published in Cell Discovery
  • The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis, 2020, published in Nature
  • Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials, 2020, published in Clinical Cancer Research
  • Comprehensive analysis of spatial architecture in primary liver cancer, 2021, published in Science Advances

The research output of Hongyang Wang extensively addresses cancer biology and immunology, with particular attention to liver-related pathologies and therapies. They contribute to advancing understanding in cancer diagnostics, treatment avenues like immunotherapy, and cellular mechanisms underlying disease progression. The work also intersects with the study of genetic aspects of hearing-related conditions, illustrating a multidisciplinary approach.

Best Publications

  • The global burden of liver disease: The major impact of China

    Fu‐Sheng Wang;Jian‐Gao Fan;Zheng Zhang;Bin Gao

  • EpCAM-positive hepatocellular carcinoma cells are tumor initiating cells with stem/progenitor cell features

    Taro Yamashita;Junfang Ji;Anuradha Budhu;Marshonna Forgues

  • Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA

    Le Qu;Jin Ding;Cheng Chen;Zhen-Jie Wu

  • Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.

    Tian Fang;Hongwei Lv;Guishuai Lv;Ting Li

  • COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.

    Xianwen Ren;Wen Wen;Xiaoying Fan;Wenhong Hou

  • Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

    Wen Wen;Wenru Su;Hao Tang;Wenqing Le

  • Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM–positive hepatic cancer stem cells

    Junfang Ji;Taro Yamashita;Anuradha Budhu;Marshonna Forgues

  • New knowledge of the mechanisms of sorafenib resistance in liver cancer.

    Yan-jing Zhu;Bo Zheng;Hong-yang Wang;Lei Chen

  • TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma

    Pengyuan Yang;Qi Jing Li;Yuxiong Feng;Yun Zhang

  • Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells

    Wen Yang;He-Xin Yan;Lei Chen;Qiong Liu

  • Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

    Qiujin Shen;Jia Fan;Xin-Rong Yang;Yexiong Tan

  • Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics

    Qiang Huang;Yexiong Tan;Peiyuan Yin;Guozhu Ye

  • A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.

    Ping Luo;Peiyuan Yin;Rui Hua;Yexiong Tan

  • Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.

    Le-Xing Yu;He-Xin Yan;Qiong Liu;Wen Yang

  • Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

    Emilie A. Bard-Chapeau;Emilie A. Bard-Chapeau;Shuangwei Li;Jin Ding;Sharon S. Zhang

  • Recurrently deregulated lncRNAs in hepatocellular carcinoma.

    Yang Yang;Lei Chen;Jin Gu;Hanshuo Zhang

  • Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study

    Jianhua Yin;Nan Li;Yifang Han;Jie Xue

  • Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

    Huiping Gao;Kesang Li;Hong Tu;Xiaorong Pan

  • Precision diagnosis and treatment of liver cancer in China

    Jing Fu;Hongyang Wang

  • Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma

    Bei-Fang Ning;Jin Ding;Chuan Yin;Wei Zhong

Frequent Co-Authors

Meng-Chao Wu
Meng-Chao Wu Second Military Medical University
Gen-Sheng Feng
Gen-Sheng Feng University of California, San Diego
Michael Q. Zhang
Michael Q. Zhang The University of Texas at Dallas
Hanfa Zou
Hanfa Zou Chinese Academy of Sciences
Rong Zeng
Rong Zeng Chinese Academy of Sciences
Mingliang Ye
Mingliang Ye Chinese Academy of Sciences
Wan Yee Lau
Wan Yee Lau Chinese University of Hong Kong
Jia Fan
Jia Fan Fudan University
Frank J. Gonzalez
Frank J. Gonzalez National Institutes of Health
Mark A. Feitelson
Mark A. Feitelson Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers besides traditional medical school, there are numerous flexible online degree options that can open doors to rewarding opportunities. Many students explore affordable online nursing programs, which make a nursing education more accessible and budget-friendly compared to on-campus options.

Current Registered Nurses (RNs) may want to consider advancing their credentials through the cheapest rn to bsn online programs. Earning a BSN can enhance patient care skills and lead to leadership roles. Meanwhile, those who already hold degrees in other fields but wish to become nurses can benefit from direct entry msn programs for non-nursing majors online, allowing a direct transition into advanced nursing practice.

For experienced nurses aiming for careers in academia or research, online phd programs in nursing offer flexible, affordable pathways to the highest level of nursing education. With these online pathways, students can balance career advancement with personal and professional commitments, making it easier to achieve their healthcare goals.

Best Scientists Citing Hongyang Wang

Trending Scientists

Recently Published Articles